| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |